26 results
In accordance with its mandate to provide guidance to Member States on health policy matters, WHO publishes vaccine position papers providing global vaccine and immunization recommendations for...
The WHO website provides a list of certain diseases for which vaccines are available, and a list of some pathogens for which vaccines and/or monoclonal antibodies (mAbs) are in development. For each...
The Consortium aims to deliver a more sustainable, efficent, and transparent approach to generating disease burden and vaccine impact estimates. It works on aggregating the estimates across a...
Yellow fever is a vector-borne disease affecting humans and non-human primates in tropical areas of Africa and South America. While eradication is not feasible due to the wildlife reservoir, large...
BACKGROUND: In 2016, the response to a yellow fever outbreak in Angola and the Democratic Republic of Congo led to a global shortage of yellow fever vaccine. As a result, a fractional dose of the...
Background: Substantial outbreaks of yellow fever in Angola and Brazil in the past 2 years, combined with global shortages in vaccine stockpiles, highlight a pressing need to assess present control...
Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for...
Work on the revised strategy, “EYE” (Eliminate Yellow fever Epidemics), started in July 2016 during the Angola and DRC outbreaks. A meeting of partners in September 2016 brought together...
On April 23, 2016, the Democratic Republic of the Congo (DRC) Ministry of Health reported an outbreak of yellow fever. As of May 24, 2016, among 41 confirmed yellow fever cases, 31 (75.6%) had...
The yellow fever outbreak declared in Angola in January 2016 soon became the largest recorded yellow fever outbreak in the country’s history. In response, the Angola Ministry of Health, supported...
Background: Since late 2015, an epidemic of yellow fever has caused more than 7334 suspected cases in Angola and the Democratic Republic of the Congo, including 393 deaths. We sought to understand...
Background
The ongoing yellow fever epidemic in Angola strains the global vaccine supply, prompting WHO to adopt dose sparing for its vaccination campaign in Kinshasa, Democratic Republic of the...
Although the latest yellow fever outbreak appears to be approaching a close, nearly 2000 suspected and confirmed cases have been reported in Angola since December, 2015.1 Aggressive vaccination...
Vaccination coverage surveys - Publication abstract:
BACKGROUND:
Following an outbreak of yellow fever in northern Uganda in December 2010, Ministry of Health conducted a massive emergency...
Multiple cornerstones have shaped the history of vaccines, which may contain live-attenuated viruses, inactivated organisms/viruses, inactivated toxins, or merely segments of the pathogen that could...
The changing epidemiology of yellow fever and continued reports of rare but serious adverse events associated with yellow fever vaccine have drawn attention to the need to revisit criteria for the...
The purpose of this document is to provide up-to-date information to support countries in making informed decisions around the appropriate yellow fever vaccine (YFV) vial presentations for routine...
Job aid for laboratory testing diseases including YF for health facilities and districts - Tanzania
Standard operating procedure for shipping yellow fever (YF) specimens to Regional Reference Laboratories (RRLs)
EQA technical report for serological testing of YF
RDT IgM Arbo panel interpretation for countries without RT-qPCR, ELISA or PRNT capability
Challenges around continuation of yellow fever activities in COVID-19 context